Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon tomography
Study Design & Technical Specifications
Sample Size / Cohort
See repository manifest
Subject / Study Model
CNS Experimental / Clinical Model
Analytical Modalities
Primary Abstract & Repository Description
Source: Allen Brain Map / BICCNEditorial Critique, Methodological Value & Reusability Guide
1. Scientific Context & Translational Bottlenecks
This resource from Allen Brain Map / BICCN ("Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon tomography") addresses critical scientific questions within Alzheimer's Disease (AD). Research in this domain currently faces major translational bottlenecks, including early preclinical stratification, heterogeneity in amyloid-tau-neurodegeneration (ATN) trajectories, and blood-brain barrier penetration of disease-modifying therapies. By focusing on key thematic elements (Allen Brain Map, Open Science, Mouse, Allen Brain Observatory, Physiology), this work contributes empirical evidence toward understanding how molecular, cellular, or systems-level alterations relate to core disease pathways such as Aβ42/40, p-tau217, p-tau181, GFAP, NfL, and APOE ε4 genotype interactions. Integrating these findings into the broader open science ecosystem helps reduce fragmentation across independent laboratories and accelerates hypothesis verification.
日本語解説を表示 (Japanese)
Allen Brain Map / BICCNより公開された本リソース（「Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon tomography」）は、アルツハイマー病（AD）領域における重要な学術的・臨床的課題に焦点を当てています。現在のアルツハイマー病（AD）研究では、発症前（プレクリニカル期）の層別化、アミロイド・タウ・神経変性（ATN）カスケードの不均一性解明、および疾患修飾薬の治療応答性予測といったトランスレーショナルリサーチ上のボトルネックが存在します。本リソースは関連キーワード（Allen Brain Map, Open Science, Mouse, Allen Brain Observatory, Physiology）を軸として、Aβ42/40比、p-tau217、p-tau181、GFAP、NfL、およびAPOE ε4遺伝子型との相互作用などの主要経路や病態メカニズムの理解に資する知見・データを提供しており、研究室や機関ごとに分散しがちな知見をオープンサイエンス基盤上で統合・検証する上で重要な位置づけを持ちます。
2. Methodology & Data Architecture Value
Structured as an open scientific dataset, this repository leverages 2-Photon Calcium across CNS Experimental / Clinical Model (cohort/experimental samples documented in source protocol). Its primary architectural value lies in providing standardized, machine-readable primary records via Allen Brain Map / BICCN under Allen Institute Terms of Use (Open Access / CC-BY). Unlike isolated summary tables in static publications, access to underlying 2-Photon Calcium distributions enables independent inspection of signal-to-noise ratios, preprocessing parameter sensitivity, and cross-modality feature extraction.
日本語解説を表示 (Japanese)
本リソースは公開科学データセットとして、神経科学実験・臨床モデル（サンプル規模: 原著プロトコルに記載されたコホート・実験サンプル）における「2-Photon Calcium」データを収録しています。Allen Brain Map / BICCNを通じてライセンス（Allen Institute Terms of Use (Open Access / CC-BY)）のもとで構造化データが提供されている点が最大の強みです。論文内の静的な要約統計量のみならず、生データや処理済み特徴量の分布に直接アクセスできるため、信号雑音比（S/N比）の検証、前処理パイプラインの感度分析、およびマルチモーダル特徴量抽出において高い学術的価値を発揮します。
3. Secondary Analysis & Reusability Scenarios
Researchers and computational neuroscientists can reuse this resource across multiple secondary workflows: (1) Cross-Cohort Harmonization & Meta-Analysis — combining these 2-Photon Calcium records with complementary repositories (such as OpenNeuro, DANDI, Agora, or Europe PMC) to increase statistical power; (2) Computational Benchmarking & Machine Learning — utilizing the documented features (Allen Brain Map, Open Science, Mouse, Allen Brain Observatory, Physiology) as training, validation, or out-of-distribution test sets for predictive biomarker discovery in Alzheimer's Disease (AD); and (3) Experimental Protocol Alignment — referencing the study design (CNS Experimental / Clinical Model, cohort/experimental samples documented in source protocol) to calibrate sample size calculations (power analysis) and endpoint selection for upcoming preclinical or clinical studies.
日本語解説を表示 (Japanese)
本リソースは以下のような二次解析・再利用シナリオに幅広く活用可能です。(1) コホート横断的ハーモナイゼーションとメタ解析：本リソースの「2-Photon Calcium」データを他の公開リポジトリ（OpenNeuro、DANDI、Agora、ADNI等）の同種データと統合し、統計的検出力（Statistical Power）を高めた統合解析を実施する。(2) 機械学習・バイオマーカー予測モデルの検証：抽出された特徴量や関連因子（Allen Brain Map, Open Science, Mouse, Allen Brain Observatory, Physiology）を、アルツハイマー病（AD）の進行予測・サブタイプ分類モデルの外部検証（External Validation）や転移学習データとして利用する。(3) 後続研究のプロトコル設計：対象モデル（神経科学実験・臨床モデル）およびサンプル規模（原著プロトコルに記載されたコホート・実験サンプル）の設計仕様を参照し、新規の非臨床試験や臨床研究におけるサンプルサイズ設計（検出力計算）や主要評価項目の妥当性検討に役立てる。
4. Methodological Limitations & Caveats
While curated from an authoritative scientific source, secondary analysts should account for potential cohort selection biases and site-specific batch effects. Specifically, when interpreting 2-Photon Calcium results in Alzheimer's Disease (AD), researchers must control for confounding variables (such as age, sex, post-mortem interval, scanner/instrument drift, or medication state) and verify compliance with open-access attribution requirements (Allen Institute Terms of Use (Open Access / CC-BY)).
日本語解説を表示 (Japanese)
信頼性の高い学術情報源から収録されていますが、二次解析や他研究との比較を行う際には、コホート選択バイアスや測定施設間差（バッチエフェクト）に留意する必要があります。特にアルツハイマー病（AD）における「2-Photon Calcium」データの解釈では、年齢・性別・罹病期間・測定機器のキャリブレーション差・併用薬などの交絡因子を適切に補正することが推奨されます。また、データや図表の二次利用時は提供元（Allen Brain Map / BICCN）の利用条件（Allen Institute Terms of Use (Open Access / CC-BY)）および適切な引用表記を遵守してください。
Data Access, Reproducibility & Analysis Starter Guide
FAIR Open Science & Clinical Metadata Verification Protocol
Quick Data Access & Structured Export
Open the primary repository directly or download structured metadata (JSON / CSV) in one click.
This resource is indexed under FAIR (Findable, Accessible, Interoperable, and Reusable) open-science metadata standards, enabling programmatic cross-referencing across Europe PMC, Semantic Scholar, ClinicalTrials.gov, and CNS Open Data.
Programmatic Data Retrieval (Python Starter Code & Recommended SDKs)
Python Quickstart: Query Europe PMC & Semantic Scholar Metadata
# Fetch structured bibliographic & open-access data via Europe PMC REST API
import urllib.request
import urllib.parse
import json
query = "Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon t"
url = f"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query={urllib.parse.quote(query)}&format=json&resultType=core"
with urllib.request.urlopen(url, timeout=10) as response:
payload = json.loads(response.read().decode("utf-8"))
results = payload.get("resultList", {}).get("result", [])
if results:
record = results[0]
print("Title:", record.get("title"))
print("Journal / Source:", record.get("journalTitle") or record.get("bookOrReportDetails"))
print("Cited By Count:", record.get("citedByCount", 0))Standardized 4-Step Workflow & Governance Checklist
Standardized Acquisition & Preprocessing Workflow
1. Programmatic Metadata & Full-Text OA Retrieval
Query Europe PMC or Crossref REST APIs using the persistent DOI/URL to retrieve structured XML full text, supplementary tables, and grant links.
2. Study Design & Cohort Eligibility Screening
Extract sample size, inclusion/exclusion criteria, and primary outcome endpoints for systematic review (PRISMA) inclusion.
3. Data Availability & Supplementary Repository Linkage
Locate accession numbers (GEO, SRA, OpenNeuro, DANDI, Zenodo, Figshare) referenced in the Data Availability section.
4. Citation Graph & Replication Tracking
Monitor supporting and contrasting citations over time to verify whether key findings have been independently replicated.
Reproducibility & Governance Checklist
- Verify whether the source is a peer-reviewed journal publication or an unrefereed preprint before clinical citation.
- Check supplementary data licenses (CC-BY / CC0) when extracting figures or summary statistics for meta-analyses.
- Cross-reference NCT clinical trial identifiers when evaluating therapeutic efficacy or biomarker endpoints.
Tags & Modalities
Bibliometrics, Peer-Review Status & Citation Export
Cross-referenced via Semantic Scholar, Europe PMC & bioRxiv
1. Citation Metrics & Context Breakdown
Citation Context Breakdown
2. Peer-Review Validation & Revision History
Verified Publication / Open Dataset Record
Metadata and license integrity verified against primary repository records.
3. Standardized Academic Citation & BibTeX Export
Allen Institute for Brain Science & BICCN Consortium (2026). Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon tomography. Allen Brain Map / BICCN. https://aging.brain-map.org/
@misc{science2026alle,
title = {Allen Brain Atlas: Visual Coding Transgenic Characterization serial two-photon tomography},
author = {Allen Institute for Brain Science and BICCN Consortium},
year = {2026},
journal = {Allen Brain Map / BICCN},
howpublished = {\url{https://aging.brain-map.org/}},
doi = {},
note = {CNS Open Data: alzheimer}
}Related Alzheimer's & Dementia Research & Datasets
Explore All DatasetsAgora Target Validation: INPP5D (inositol polyphosphate-5-phosphatase D) in Alzheimer’s Disease
This gene is a member of the inositol polyphosphate-5-phosphatase (INPP5) family and encodes a protein with an N-terminal SH2 domain, an inositol phosphatase domain, and two C-terminal protein interaction domains. Expression of this protein is restricted to hematopoietic cells where its movement from the cytosol to the...
Agora Target Validation: NRN1 (neuritin 1) in Alzheimer’s Disease
This gene encodes a member of the neuritin family, and is expressed in postmitotic-differentiating neurons of the developmental nervous system and neuronal structures associated with plasticity in the adult. The expression of this gene can be induced by neural activity and neurotrophins. The encoded protein contains a ...
Agora Target Validation: BIN1 (bridging integrator 1) in Alzheimer’s Disease
This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, syna...
Allen Brain Atlas: Multi-plane optical physiology during image change detection
Time series of behavioral variables and neural activity measured with multi-plane in vivo 2-photon imaging in mice performing a visual change detection task where mice were trained with image set A and tested with a novel image set B... Freely accessible open data product maintained by the Allen Institute for Brain Science.
Agora Target Validation: HTRA1 (HtrA serine peptidase 1) in Alzheimer’s Disease
This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of ...
Agora Target Validation: APOE (apolipoprotein E) in Alzheimer’s Disease
The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mu...
Active Clinical Trials & Pipeline in Alzheimer's & Dementia
View Clinical PipelineRelated Data & Resources
Academic Research & Medical Information Disclaimer
This page provides structured scientific metadata, methodological critiques, and open-data reusability guidelines intended strictly for neuroscience researchers and data scientists. It does not constitute medical advice, clinical diagnosis, or treatment recommendations.
Was this resource helpful?
Help improve data curation by sharing your feedback.